26 March 2018 - The Federal Government will slash the price that patients pay for 11 medicines used to treat asthma, diabetes, arthritis, cancer and eye disease — but a vaccine for meningococcal is under review.
Federal Health Minister Greg Hunt will today announce a series of new Pharmaceutical Benefits Scheme listings to start from April 1.
The type 2 diabetes oral medicines Forziga, Xigduo and Qtern will also be added to the PBS. The Government will expand eligibility for subsidised access to the diabetes medicines Jardiance, Jardiamet, Trajentamet, Galvus and Galvumet. The listings were recommended by the PBAC.